Table 4.

Survival based on the site of primary: maximum survival was for breast secondaries (24 months) and least for lung (6 months) (P-value 0.001)

Site of primary	Life expectancy < 6 months, number and percentage	Life expectancy > 6 months, number and percentage	Total
Breast	8 25.80%	23 74.20%	31 100%
Lung	26 61.90%	16 38.10%	42 100%
Prostate	3 18.80%	13 81.30%	16 100%
Thyroid	4 50.00%	4 50.00%	8 100%
Kidney	2 100.00%		2 100%
Others	8 100.00%		8 100%
Undetected	4 100.00%		4 100%
Total	55 49.50%	56 50.50%	111 100%